Nonalcoholic fatty liver disease as a component of the metabolic syndrome (Q37140029)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on February 2008

Language	Label	Description	Also known as
English	Nonalcoholic fatty liver disease as a component of the metabolic syndrome	scientific article published on February 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

Nonalcoholic fatty liver disease as a component of the metabolic syndrome (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

metabolic syndrome

1 reference

based on heuristic

inferred from title

fatty liver disease

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

Mouen A Khashab

1

object named as

Mouen A Khashab

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

author name string

Suthat Liangpunsakul

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Naga Chalasani

3

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Current gastroenterology reports

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

73-80

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS11894-008-0012-0

21 January 2018

Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in non-alcoholic steatohepatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fatty liver and the metabolic syndrome among Shanghai adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and etiology of persistently elevated alanine aminotransferase levels in healthy Iranian blood donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoids and the regulation of body fat: the smoke is clearing

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patients with elevated baseline liver enzymes do not have higher frequency of hepatotoxicity from lovastatin than those with normal baseline liver enzymes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of Hepatic Steatosis in Morbidly Obese Persons After Gastric Bypass

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of fatty liver in children and adolescents.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinicopathologic spectrum and management of nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pravastatin in patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of weight reduction on hepatic abnormalities in overweight patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and Trends in Obesity Among US Adults, 1999-2000

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unexplained elevations in alanine aminotransferase in individuals with the metabolic syndrome: results from the third National Health and Nutrition Survey (NHANES III).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic syndrome and risk of cardiovascular disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18417046

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11894-008-0012-0

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37140029&oldid=2241685066"